argenx SE (ARGX)
371.16
+9.00
(+2.49%)
USD |
NASDAQ |
May 31, 16:00
370.91
-0.25
(-0.07%)
After-Hours: 20:00
argenx Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 527.02M |
| June 30, 2022 | -232.34M |
| June 30, 2021 | -492.32M |
| June 30, 2019 | -594.94M |
| June 30, 2018 | -32.50M |
| June 30, 2017 | -104.54M |
| Date | Value |
|---|---|
| June 30, 2016 | -0.693M |
| June 30, 2015 | -0.738M |
| June 30, 2014 | -0.0004M |
| March 31, 2014 | 0.0468M |
| June 30, 2013 | 0.0709M |
| March 31, 2013 | 0.0384M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-594.94M
Minimum
Jun 2019
527.02M
Maximum
Jun 2023
-198.15M
Average
-362.33M
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Koninklijke Philips NV | -- |
| Trinity Biotech PLC | -13.96M |
| NuCana PLC | 0.0545M |
| uniQure NV | 63.98M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | -4.22% |